All the new drugs ap­proved in 2023: Alzheimer's and gene ther­a­py cap a five-year high

Af­ter kick­ing off 2023 with a po­ten­tial megablock­buster in Ei­sai and Bio­gen’s new Alzheimer’s drug Leqem­bi, in to­tal­i­ty the FDA signed off on 10 more nov­el drug ap­provals in 2023 when com­pared to last year.

The 57 nov­el drugs ap­proved in 2023 (not count­ing gene ther­a­pies or vac­cines) are the most since 2018 — the year of Gilead’s block­buster HIV drug Bik­tarvy, which gen­er­at­ed $10.4 bil­lion in 2022 sales.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER